vs
Side-by-side financial comparison of MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) and PennyMac Mortgage Investment Trust (PMT). Click either name above to swap in a different company.
PennyMac Mortgage Investment Trust is the larger business by last-quarter revenue ($93.6M vs $49.9M, roughly 1.9× MARAVAI LIFESCIENCES HOLDINGS, INC.). PennyMac Mortgage Investment Trust runs the higher net margin — 56.0% vs -71.6%, a 127.5% gap on every dollar of revenue. On growth, MARAVAI LIFESCIENCES HOLDINGS, INC. posted the faster year-over-year revenue change (-11.8% vs -13.3%). Over the past eight quarters, PennyMac Mortgage Investment Trust's revenue compounded faster (12.3% CAGR vs -11.9%).
Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.
PennyMac Mortgage Investment Trust is a U.S.-headquartered real estate investment trust specializing in residential mortgage assets. It invests in performing and non-performing mortgage loans, mortgage-backed securities, and credit risk transfer instruments, operating across investment management and mortgage servicing segments in the U.S. housing market.
MRVI vs PMT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $49.9M | $93.6M |
| Net Profit | $-35.7M | $52.4M |
| Gross Margin | 25.8% | — |
| Operating Margin | -117.9% | 38.6% |
| Net Margin | -71.6% | 56.0% |
| Revenue YoY | -11.8% | -13.3% |
| Net Profit YoY | -37.7% | 12.5% |
| EPS (diluted) | $-0.24 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $49.9M | $93.6M | ||
| Q3 25 | $41.6M | $99.2M | ||
| Q2 25 | $47.4M | $70.2M | ||
| Q1 25 | $46.9M | $44.5M | ||
| Q4 24 | $56.6M | $107.9M | ||
| Q3 24 | $69.0M | $80.9M | ||
| Q2 24 | $69.4M | $71.2M | ||
| Q1 24 | $64.2M | $74.2M |
| Q4 25 | $-35.7M | $52.4M | ||
| Q3 25 | $-25.6M | $58.3M | ||
| Q2 25 | $-39.6M | $7.5M | ||
| Q1 25 | $-29.9M | $9.7M | ||
| Q4 24 | $-25.9M | $46.5M | ||
| Q3 24 | $-97.1M | $41.4M | ||
| Q2 24 | $-9.8M | $25.4M | ||
| Q1 24 | $-12.1M | $47.6M |
| Q4 25 | 25.8% | — | ||
| Q3 25 | 13.6% | — | ||
| Q2 25 | 16.4% | — | ||
| Q1 25 | 16.5% | — | ||
| Q4 24 | 34.3% | — | ||
| Q3 24 | 46.7% | — | ||
| Q2 24 | 44.4% | — | ||
| Q1 24 | 40.3% | — |
| Q4 25 | -117.9% | 38.6% | ||
| Q3 25 | -98.6% | 47.4% | ||
| Q2 25 | -139.8% | 24.2% | ||
| Q1 25 | -104.9% | -14.2% | ||
| Q4 24 | -66.7% | 51.1% | ||
| Q3 24 | -239.9% | 32.8% | ||
| Q2 24 | -19.4% | 40.2% | ||
| Q1 24 | -29.4% | 43.6% |
| Q4 25 | -71.6% | 56.0% | ||
| Q3 25 | -61.4% | 58.7% | ||
| Q2 25 | -83.5% | 10.7% | ||
| Q1 25 | -63.9% | 21.8% | ||
| Q4 24 | -45.8% | 43.1% | ||
| Q3 24 | -140.6% | 51.2% | ||
| Q2 24 | -14.1% | 35.7% | ||
| Q1 24 | -18.8% | 64.2% |
| Q4 25 | $-0.24 | $0.49 | ||
| Q3 25 | $-0.18 | $0.55 | ||
| Q2 25 | $-0.27 | $-0.04 | ||
| Q1 25 | $-0.21 | $-0.01 | ||
| Q4 24 | $-0.21 | $0.45 | ||
| Q3 24 | $-0.68 | $0.36 | ||
| Q2 24 | $-0.07 | $0.17 | ||
| Q1 24 | $-0.09 | $0.39 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $216.9M | $190.5M |
| Total DebtLower is stronger | $291.8M | $1.1B |
| Stockholders' EquityBook value | $212.4M | $1.9B |
| Total Assets | $770.6M | $21.3B |
| Debt / EquityLower = less leverage | 1.37× | 0.58× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $216.9M | $190.5M | ||
| Q3 25 | $243.6M | $181.0M | ||
| Q2 25 | $269.9M | $108.6M | ||
| Q1 25 | $285.1M | $204.2M | ||
| Q4 24 | $322.4M | $103.2M | ||
| Q3 24 | $578.2M | $102.8M | ||
| Q2 24 | $573.2M | $336.3M | ||
| Q1 24 | $561.7M | $343.3M |
| Q4 25 | $291.8M | $1.1B | ||
| Q3 25 | $292.8M | $299.0M | ||
| Q2 25 | $293.9M | $1.2B | ||
| Q1 25 | $294.9M | $968.4M | ||
| Q4 24 | $295.9M | $1.0B | ||
| Q3 24 | $521.7M | $5.2B | ||
| Q2 24 | $522.5M | $5.4B | ||
| Q1 24 | $523.3M | $5.1B |
| Q4 25 | $212.4M | $1.9B | ||
| Q3 25 | $245.4M | $1.9B | ||
| Q2 25 | $265.9M | $1.9B | ||
| Q1 25 | $300.6M | $1.9B | ||
| Q4 24 | $325.3M | $1.9B | ||
| Q3 24 | $344.9M | $1.9B | ||
| Q2 24 | $434.7M | $1.9B | ||
| Q1 24 | $410.7M | $2.0B |
| Q4 25 | $770.6M | $21.3B | ||
| Q3 25 | $849.2M | $18.5B | ||
| Q2 25 | $897.0M | $16.8B | ||
| Q1 25 | $959.8M | $14.9B | ||
| Q4 24 | $1.0B | $14.4B | ||
| Q3 24 | $1.3B | $13.1B | ||
| Q2 24 | $1.4B | $12.1B | ||
| Q1 24 | $1.4B | $12.3B |
| Q4 25 | 1.37× | 0.58× | ||
| Q3 25 | 1.19× | 0.16× | ||
| Q2 25 | 1.11× | 0.65× | ||
| Q1 25 | 0.98× | 0.51× | ||
| Q4 24 | 0.91× | 0.52× | ||
| Q3 24 | 1.51× | 2.70× | ||
| Q2 24 | 1.20× | 2.76× | ||
| Q1 24 | 1.27× | 2.60× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-22.8M | $-7.2B |
| Free Cash FlowOCF − Capex | $-24.9M | — |
| FCF MarginFCF / Revenue | -49.9% | — |
| Capex IntensityCapex / Revenue | 4.2% | — |
| Cash ConversionOCF / Net Profit | — | -137.76× |
| TTM Free Cash FlowTrailing 4 quarters | $-70.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-22.8M | $-7.2B | ||
| Q3 25 | $-15.2M | $-1.3B | ||
| Q2 25 | $-10.3M | $-2.0B | ||
| Q1 25 | $-9.4M | $-594.3M | ||
| Q4 24 | $-14.6M | $-2.7B | ||
| Q3 24 | $13.1M | $-983.8M | ||
| Q2 24 | $17.4M | $243.8M | ||
| Q1 24 | $-8.5M | $-342.4M |
| Q4 25 | $-24.9M | — | ||
| Q3 25 | $-18.1M | — | ||
| Q2 25 | $-13.1M | — | ||
| Q1 25 | $-14.6M | — | ||
| Q4 24 | $-20.5M | — | ||
| Q3 24 | $4.5M | — | ||
| Q2 24 | $7.9M | — | ||
| Q1 24 | $-14.1M | — |
| Q4 25 | -49.9% | — | ||
| Q3 25 | -43.4% | — | ||
| Q2 25 | -27.7% | — | ||
| Q1 25 | -31.2% | — | ||
| Q4 24 | -36.2% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 11.4% | — | ||
| Q1 24 | -22.0% | — |
| Q4 25 | 4.2% | — | ||
| Q3 25 | 7.0% | — | ||
| Q2 25 | 6.1% | — | ||
| Q1 25 | 11.2% | — | ||
| Q4 24 | 10.3% | — | ||
| Q3 24 | 12.4% | — | ||
| Q2 24 | 13.8% | — | ||
| Q1 24 | 8.8% | — |
| Q4 25 | — | -137.76× | ||
| Q3 25 | — | -22.26× | ||
| Q2 25 | — | -267.53× | ||
| Q1 25 | — | -61.39× | ||
| Q4 24 | — | -58.08× | ||
| Q3 24 | — | -23.76× | ||
| Q2 24 | — | 9.59× | ||
| Q1 24 | — | -7.19× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MRVI
| Cygnus Segment | $27.2M | 54% |
| Other | $18.4M | 37% |
| Shipping And Handling | $4.3M | 9% |
PMT
| Other | $55.0M | 59% |
| Interest Rate Sensitive Strategies | $31.4M | 34% |
| Correspondent Production | $7.2M | 8% |
